4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQUSD
9.96 USD
0.46 (4.85%)🔴AT CLOSE (AS OF 04:15 PM EDT)
🔴Market: CLOSED
Open?$9.57
High?$10.05
Low?$9.57
Prev. Close?$9.48
Volume?460.2K
Avg. Volume?802.2K
VWAP?$9.88
Rel. Volume?0.57x
Bid / Ask
Bid?$9.95 × 100
Ask?$9.96 × 300
Spread?$0.01
Midpoint?$9.96
Valuation & Ratios
Market Cap?484.0M
Shares Out?51.1M
Float?50.4M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?0.96
EPS?-$2.74
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.39Strong
Quick Ratio?9.39Strong
Cash Ratio?1.37Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
0.96CHEAP
P/S?
5.68FAIR
P/FCF?
N/A
EV/EBITDA?
-2.7CHEAP
EV/Sales?
4.97FAIR
Returns & Efficiency
ROE?
-27.7%WEAK
ROA?
-24.7%WEAK
Cash Flow & Enterprise
FCF?$-109618000
Enterprise Value?$423.7M
Related Companies
Loading...
News
Profile
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Employees
196
Market Cap
484.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680